Insider Trading & Ownership - Ogden Christopher

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Ogden Christopher
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-08-20
Sale
2024-08-22
5:59 pm
CytomX Therapeutics Inc.CTMXOgden Christopher
Chief Financial Officer
1,984$1.2291$2,439108,077
(Direct)
View
2024-03-19
Sale
2024-03-21
4:38 pm
CytomX Therapeutics Inc.CTMXOgden Christopher
SVP, Finance and Accounting
2,971$2.0855$6,19685,686
(Direct)
View
2023-12-20
Sale
2023-12-22
4:10 pm
CytomX Therapeutics Inc.CTMXOgden Christopher
SVP, Finance and Accounting
1,990$1.3806$2,74748,657
(Direct)
View
2023-03-16
Sale
2023-03-20
6:43 pm
CytomX Therapeutics Inc.CTMXOgden Christopher
SVP, Finance and Accounting
516$1.9793$1,02137,772
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-08-20
Exercise
2024-08-22
5:59 pm
N/A
N/A
CytomX Therapeutics Inc.CTMXOgden Christopher
Chief Financial Officer
6,875$0108,077
(Direct)
View
2024-06-12
Option Award
2024-06-14
4:24 pm
N/A
2034-06-11
CytomX Therapeutics Inc.CTMXOgden Christopher
Chief Financial Officer
92,500$0178,186
(Direct)
View
2024-01-18
Option Award
2024-01-19
8:41 pm
N/A
2034-01-17
CytomX Therapeutics Inc.CTMXOgden Christopher
SVP, Finance and Accounting
269,000$0317,657
(Direct)
View
2023-12-17
Exercise
2023-12-19
7:58 pm
N/A
N/A
CytomX Therapeutics Inc.CTMXOgden Christopher
SVP, Finance and Accounting
6,875$057,522
(Direct)
View
2023-02-02
Option Award
2023-02-06
4:47 pm
N/A
2033-02-01
CytomX Therapeutics Inc.CTMXOgden Christopher
SVP, Finance and Accounting
175,000$0188,288
(Direct)
View
2022-08-10
Option Award
2022-08-12
4:59 pm
N/A
2032-08-09
CytomX Therapeutics Inc.CTMXOgden Christopher
SVP, Finance and Accounting
96,250$096,250
(Direct)
View

Ownership
2022-03-09
6:06 pm
N/A
N/A
CytomX Therapeutics Inc.CTMXOgden Christopher
See Remarks
0$089,863
(Direct)
View